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increase in medical cost, a 10.5% increase in nonmedical 
cost, and a 4.1% increase in caregiving time. A one-point in-
crease in BDRS score was associated with a 7.6% increase in 
medical cost, a 3.9% increase in nonmedical cost and an 
8.7% increase in caregiving time.  Conclusions: Both func-
tional impairment and patient dependence were associated 
with higher costs of care and caregiving time. Measures of 
functional impairment and patient dependence provide 
unique and incremental information on the overall impact 
of AD on patients and their caregivers. 
 Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 The high cost of caring for patients with Alzheimer 
disease (AD) is widely known, with annual costs exceed-
ing USD 80–100 billion in the USA  [1] . As the disease 
progresses, the patients’ function worsens and they be-
come increasingly dependent on others to supervise and 
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 Abstract 
 Background/Aims: To examine the incremental effect of pa-
tients’ dependence on others, on cost of medical and non-
medical care, and on informal caregiving hours over time. 
 Methods: Data are obtained from 172 patients from the Pre-
dictors Study, a large, multicenter cohort of patients with 
probable Alzheimer disease (AD) followed annually for 4 
years in 3 University-based AD centers in the USA. Enroll-
ment required a modified Mini-Mental State Examination 
score  6 30. We examined the effects of patient dependence 
(measured by the Dependence Scale, DS) and function (mea-
sured by the Blessed Dementia Rating Scale, BDRS) on med-
ical care cost, nonmedical care cost, and informal caregiving 
time using random effects regression models.  Results: A 
one-point increase in DS score was associated with a 5.7% 
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perform cognitively demanding and even basic physical 
tasks. The relationship between patients’ functional defi-
cits and higher cost of care has been clearly demonstrated 
in cross-sectional settings  [2–5] . In the Predictors Study, 
we examined longitudinal relationships between patients’ 
functional deficits and several cost outcomes, including 
medical (e.g. hospitalizations) and informal caregiving 
costs (e.g. cost of caregivers’ time)  [4, 5] . We found the 
relationship between increasing functional deficits and 
higher costs consistent over time.
 However, functional deficits do not fully describe pa-
tients’ dependence on other individuals and may only 
provide a partial explanation of variation in AD-related 
costs  [6–10] . To address this issue, the Dependence Scale 
(DS) was developed to directly measure the amount of 
assistance AD patients require  [7] . Earlier studies dem-
onstrated that, aside from patients’ cognition and func-
tion, the DS measures related but distinct aspects of dis-
ability in AD  [8–10] . Two recent studies began to exam-
ine the effect of dependence on costs of care  [11, 12] . 
Murman et al.  [11] conducted a pathway analysis to ex-
amine the effect of the DS on cost by payer (e.g. Medi-
care). The results showed that the DS was partially ex-
plained by a combination of clinical characteristics (e.g. 
cognitive impairment), and that the DS, in turn, partial-
ly explained variations in total societal costs. While this 
provides additional support for the DS as a predictor of 
cost, the omission of a functional measure limits any 
conclusions on the utility of the DS as a predictor sepa-
rate from functional deficits. To address this issue, we 
conducted an analysis using baseline data of the Predic-
tors Study and examined the incremental effect of the DS 
on cost  [12] . We showed that, after controlling for func-
tional deficits, the DS was significantly associated with 
total cost of care, and that functional deficits and depen-
dence related differently to different cost components. 
However, since all patients were at early disease stages at 
baseline, few used any nonmedical care (e.g. home health 
aides), precluding a detailed analysis on the relationship 
between the DS and this important cost component. 
Also, since both studies were cross-sectional, whether 
this relationship is consistent over time has yet to be de-
termined.
 In this study, we aim to extend previous work in two 
directions: (1) to investigate whether the relationships be-
tween increasing dependence and costs of care observed 
in cross-sectional settings are consistent over time, and 
(2) to examine the nonmedical care cost trajectory and 
estimate its relationship with patient dependence. By es-
timating these relationships, we hope to provide useful 
data for future evaluations of disease cost trajectories, 
provide insights into future areas for research, clinical 
practice and disease management, and influence health 
care policy and financing.
 Methods 
 Sample 
 The sample was drawn from the Predictors 2 cohort, and con-
sisted of 204 patients with probable AD recruited between 1998 
and 2004 from the Columbia University Medical Center, Johns 
Hopkins School of Medicine, and the Massachusetts General 
Hospital  [13, 14] . The inclusion and exclusion criteria have been 
fully described elsewhere  [13, 14] . Briefly, subjects met DSM-III-R 
criteria for primary degenerative dementia of the Alzheimer type 
and NINDS-ADRDA criteria for probable AD. Enrollment re-
quired a modified Mini-Mental State Examination (mMMS) 
score  6 30  [15] . The mMMS (range 0–57) is an expanded measure 
of global cognitive status based on the original Folstein Mini-
Mental State Exam (MMSE)  [16] , and includes the Wechsler Adult 
Intelligence Scale Digit Span subtest, as well as additional atten-
tion/calculation, general knowledge, language, and construction 
items. A conversion equation, mMMS = 1.73 MMSE + 2.81, can 
be used to relate the mMMS to the original MMSE. An mMMS 
score  6 30 therefore is equivalent to a score of approximately  6 16 
on the original MMSE. Because patients were followed at aca-
demic AD centers, they were well characterized, with high de-
grees of certainty in their AD diagnosis. To date, postmortem 
diagnoses have been completed for 96 patients, 92 (96%) of whom 
had AD-type pathological changes based on CERAD and NIA-
Reagan criteria  [17, 18] .
 Recruitment of patients began in 1998 and is ongoing. After 
the baseline visit, all patients were re-evaluated semiannually, 
with annual assessments of health care utilization and costs. At 
the time of these analyses, baseline data were collected for 13.3% 
of patients in 1998, 8.3% in 1999, 24.3% in 2000, 26.0% in 2001, 
15.5% in 2002, 11.1% in 2003, and 1.1% in 2004. At present, 82.4% 
have had at least one follow-up assessment and about a third had 
3 assessments. Median follow-up for the cohort at this point was 
2.5 years; maximum was 7. Patients who did not respond at a par-
ticular visit could respond at a subsequent visit. Differences in the 
number of observations during follow-up reflect both continuous 
accrual of patients and patient deaths (7%). Missed visits during 
follow-up were rare: 15.6% missed 1, 2.5% missed 2, and 1% 
missed 3 visits.
 The construction of our analysis sample has been described in 
detail in earlier reports  [4, 5] . Briefly, because patterns of health 
care utilization differ substantially for community and institu-
tionalized patients  [19, 20] , we excluded visits during which pa-
tients lived in an institutional setting. We further excluded visits 
for which there were missing cost and DS data. In addition, we 
excluded from the analysis 3 different visits (from 2 patients) with 
reports of zero use of any resource items. Because the number of 
observations with zero use was so small, excluding them did not 
change the distribution of the dependent variables in the sample. 
The analysis sample consisted of 428 observations from 172 pa-
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 Measures 
 Patient characteristics and cost outcomes used in this study 
are briefly described below. Details of the measures and the cost-
ing methods used were reported in earlier studies  [4, 5] .
 Dependent Variables 
 Informants reported patients’ utilization of medical, nonmed-
ical, and informal care. Domains of medical care included hospi-
talization, outpatient treatment and procedures, assistive devices, 
and medications. Domains of nonmedical care included over-
night respite care, adult daycare, and home health aides. Quanti-
ties of care used were annualized and converted into costs using 
prices obtained from public databases. All costs values were ad-
justed to constant 2005 dollars. Informal caregiving time for basic 
and instrumental activities of daily living and for supervision was 
obtained from up to 3 caregivers for each patient. Hours of infor-
mal care provided per day for each caregiving task were asked in 
the following categories: 0,  ^  3, 3–6, 6–9, 9–12, and  1 12 h. We 
transformed these categories into continuous values using the 
mean of each category and top-coded the last category to 12 h. We 
summed the hours for each patient to obtain an estimate of total 
caregiving hours.
 Independent Variables 
 Our main independent variables are the DS and the Blessed 
Dementia Rating Scale (BDRS).
 Dependence Scale 
 The DS consists of 13 items, representing a wide range of care 
required by a patient, from items related to early disease stages, 
such as needing reminders, to those related to more advanced dis-
ease stages, such as needing to be fed  [7] .  Table 1 presents the entire 
DS questionnaire. All items deal with patients’ needs, rather than 
what they actually received. The instrument is designed to be ad-
ministered to a reliable informant who lives with the patient or one 
who is well informed about the patient’s daily activities and needs. 
With the exception of the first 2 items (needs reminders to manage 
chores, needs help to remember important things such as appoint-
ments) which are coded as 0 (no), 1 (occasionally, at least once a 
month), and 2 (frequently, at least once a week), responses to the 
rest of the items are coded dichotomously and indicate whether 
the patient requires assistance with a particular item (0 = no, 1 = 
yes). The total DS score is the sum of scores on all 13 items
(range = 0–15), and provides a continuous index of progressively 
greater dependence, with higher scores indicating increasing de-
pendence. Reliability and validity of the scale have been estab-
lished, with reliability coefficients ranging from 0.66 to 0.93  [7] .
 Blessed Dementia Rating Scale 
 Functional capacity was measured by the BDRS parts I (in-
strumental activities of daily living) and II (basic activities of dai-
ly living)  [6] . Response options for the 7 instrumental activities of 
daily living items (e.g. difficulty in doing chores around the 
house) were none (0), some difficulty (0.5), and a lot of difficulty 
(1). Response options for the 3 basic activities of daily living items 
(e.g. eating) ranged from 0 to 3, with higher scores indicating 
more difficulty. For example, for the item on eating, the response 
options were eat cleanly (0), messily or only with a spoon (1), only 
able to eat simple solids such as pudding (2), and need to be
fed (3). The total BDRS score is the sum of scores on all 10 items 
(range = 0–17), with higher scores indicating worse function. Re-
liability and validity of the scale have been established, with reli-
ability coefficients ranging from 0.60 to 0.80  [6] .
 Other Independent Variables 
 Patients’ medical histories at baseline were used to construct 
a modified version of the Charlson Comorbidity Index  [21, 22] . 
Patients’ age, ethnicity, sex, and education were recorded at base-
line and marital status was recorded at each visit.
 Analysis 
 We used random effects models to estimate the effects of pa-
tient characteristics on medical cost, nonmedical cost, and infor-
mal caregiving time  [23] . With this framework, we hypothesize 
that costs are predicted by a combination of fixed effects that are 
common to all individuals in the population or common to groups 
of individuals, and random effects that indicate individual spe-
Table 1. The DS Questionnaire
A Does the patient need reminders or advice to manage chores, 
do shopping, cooking, play games, or handle money?
B Does the patient need help to remember important things 
such as appointments, recent events, or names of family or 
friends?
C Does the patient need frequent (at least once a month) help 
finding misplaced objects, keeping appointments, or main-
taining health or safety (locking doors, taking medication)?
D Does the patient need household chores done for him/her?
E Does the patient need to be watched or kept company when 
awake?
F Does the patient need to be escorted when outside?
G Does the patient need to be accompanied when bathing or 
eating?
H Does the patient have to be dressed, washed, and groomed?
I Does the patient have to be taken to the toilet regularly to 
avoid incontinence?
J Does the patient have to be fed?
K Does the patient need to be turned, moved, or transferred?
L Does the patient wear a diaper or a catheter?
M Does the patient need to be tube fed?
Items A and B are coded as follows: no = 0; occasionally (i.e., 
at least once a month) = 1; frequently (i.e., at least once a week) = 
2. The other items are coded as follows: no = 0; yes = 1. The total 
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cific variations. The fixed effects parameters have the usual inter-
pretation as the average effect of each explanatory variable on 
costs. The random effects are interpreted as deviations from the 
mean for each individual, and therefore model the magnitude of 
unobserved heterogeneity. Specifically, to deal with clustering of 
observations within the individual over time, we included a ran-
dom intercept to estimate the between-individual variations in 
cost at baseline, and a random slope to estimate between-indi-
vidual variations in changes in cost over time.
 Because the distributions of the dependent variables were 
highly positively skewed, we examined log-transformed depen-
dent variables. Therefore, the coefficient estimates are semi-elas-
ticities, for which the interpretation requires some care. For con-
tinuous explanatory variables, the coefficient beta estimates pro-
portional change in the cost outcome for a unit change in the 
explanatory variable. That is, for a unit increase in the explana-
tory variable, cost increases by 100 beta %. For dichotomous ex-
planatory variables, the corresponding proportional change in 
cost of the explanatory variable from the reference group is esti-
mated by Kennedy  [24] . We interpreted these proportional chang-
es as marginal effects of the explanatory variables, and estimated 
the positive portion of each dependent variable. All analyses were 
performed using Stata 9.0  [25] .
 As in our baseline analysis, we were concerned about the rela-
tionship between our main independent variables and other clin-
ical characteristics (e.g. MMSE). We followed our baseline analy-
sis and examined two sets of models, a trimmed model that con-
trolled for demographic variables only, and a full model that also 
controlled for other clinical variables  [12] . We present data for the 
trimmed models only because results suggest that they performed 
just as well as the full models.
 Results 
 Sociodemographic and Clinical Characteristics 
 Descriptive statistics of patients’ sociodemographic 
characteristics at baseline and at each follow-up year are 
provided in  table 2 to give a sense of the characteristics of 
the cohort over time. At baseline, the average patient was 
75.1 years old. Slightly over half were women (55.8%). 
Most patients were non-Hispanic white (95.3%), well-ed-
ucated (average 14.5 years of schooling), and married 
(67.4%).
 Table 3 presents patients’ clinical characteristics at 
baseline for the entire sample and for the subset of patients 
with complete 4-year follow-up data. Because of study in-
clusion criteria, all patients were at the early stages of AD 
at baseline, with a mean MMSE score of 22.1 (SD = 3.8), 
mean BDRS score of 2.8 (SD = 1.4), and mean DS score of 
5.1 (SD = 2.3). Behavioral problems (42.4%) and psychotic 
symptoms (31.0%) were common. About 20% had depres-
sive symptoms; 14.5% exhibited extrapyramidal symp-
toms (EPS). At baseline, the subset of patients with com-
plete 4-year follow-up data was similar to other patients 
regarding DS, BDRS, and MMSE scores. However, the 
prevalence of behavioral problems, psychotic symptoms, 
depressive symptoms, and EPS was lower. As expected, 
patients’ cognition and function declined and dependence 
increased over time. The presence of EPS and psychotic 
Table 2. Descriptive statistics of sociodemographic characteristics
All samples Baseline Year 1 Year 2 Year 3 Year 4
(n = 428) (n = 172) (n = 103) (n = 71) (n = 43) (n = 32)
Age at baseline (mean 8 SD), years 74.987.6 75.187.5 75.188.0 75.788.1 74.086.1 73.987.8
Female, % 50.0 55.8 46.6 50.7 30.2 53.1
Race, %
White 95.8 95.3 97.1 94.4 95.3 96.9
Black 4.2 4.7 2.9 5.6 4.7 3.1
Years of schooling (mean 8 SD) 14.783.3 14.583.3 14.983.1 14.883.3 15.283.5 14.183.7
Marital status, %
Married 71.0 67.4 70.9 71.8 86.0 71.9
Widowed 23.1 25.0 22.3 22.5 14.0 25.0
Other 5.8 7.6 6.8 5.6 0.0 3.1
Site, %
Columbia 53.5 52.3 43.7 57.7 60.5 65.6
Johns Hopkins 20.8 22.1 22.3 14.1 18.6 28.1
Massachusetts General 25.7 25.6 34.0 28.2 20.9 6.3
At baseline, data were collected from 172 patients. At year 1 and each year thereafter through year 4, data were collected from 103, 
71, 43, and 32 patients for a total number of 428 observations. Differences in the number of follow-up visits mainly reflected the stag-
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symptoms seemed to have increased over time, while the 
presence of behavioral problems and depressive symp-
toms fluctuated. The number of comorbidities remained 
relatively stable over time (mean = 0.7, SD = 0.9).
 Unadjusted Medical and Nonmedical Costs and 
Weekly Caregiving Hours 
 At baseline, informants reported an average annual 
cost of USD 8,600 for medical care and USD 1,500 for 
nonmedical care.  Figure 1 presents descriptive data on 
medical and nonmedical cost by DS scores for all obser-
vations, regardless of visit. Medical care cost increased 
from USD 4,831 when DS score = 0 to USD 16,937 when 
DS score  6 14. Nonmedical cost followed a somewhat dif-
ferent trend. Patients had little nonmedical cost until 
reaching mild levels of dependence before cost started to 
increase, from USD 2,828 when DS score = 6 to USD 
21,072 when DS score  6 14. These results were combined 
to show that total direct cost increased from USD 4,831 
when DS score = 0 to over USD 38,009 when DS score 
 6 14. At baseline, informants reported that patients re-
ceived an average of 21.2 h of informal care per week. 
 Figure 2 presents descriptive data on informal caregiving 
hours per week by DS scores for all observations, regard-
less of visit. Informal caregiving time increased from 7.9 
h per week when DS score = 0 to 26.5 h per week when 
DS score  6 14.
Table 3. Patient clinical characteristics
All samples at 
baseline
(n = 172)
Subsample with complete 4-year follow-up data (n = 32)
baseline year 1 year 2 year 3 year 4
DS total score (mean 8 SD) 5.182.3 5.282.0 5.982.1 6.982.9 8.383.4 8.982.9
BDRS total score (mean 8 SD) 2.881.4 2.981.3 3.381.6 4.081.8 4.681.9 5.281.4
MMSE score (mean 8 SD) 22.183.8 23.083.5 21.485.8 19.686.9 18.287.6 17.28
Modified comorbidity index 0.7 (0.9) 0.7 (0.8) 0.6 (0.7) 0.7 (0.8) 0.7 (0.8) 0.8 (0.9)
Behavioral problems, % 42.4 28.9 55.9 57.6 54.8 60.0
EPS, % 14.5 10.8 16.7 21.4 22.7 37.5
Depressive symptoms, % 19.6 15.8 23.5 15.2 16.1 26.7
Psychotic symptoms, % 31.0 21.1 20.6 30.3 40.0 46.7
DS score: range = 0–15; BDRS score: range = 0–17; MMSE score: range = 0–30. EPS = Extrapyramidal signs.
Table 4. Random effects models of medical cost, nonmedical cost, and informal caregiving hours over time







Year –0.038 (0.036) –0.038 0.171* (0.099) 0.180 0.031 (0.029) 0.032
DS score 0.055** (0.026) 0.057 0.109* (0.067) 0.105 0.040** (0.022) 0.041
BDRS score 0.074* (0.046) 0.076 0.034** (0.144) 0.038 0.084** (0.039) 0.087
Charlson’s comorbidity score 0.177*** (0.056) 0.192 0.086 (0.152) 0.077 –0.016 (0.043) –0.017
Women (1 = yes, 0 = no) –0.319*** (0.102) –31.942 0.110*** (0.030) 11.030 –0.042* (0.079) –4.151
Younger than 65 (1 = yes, 0 = no) –0.106 (0.162) –10.573 0.457 (0.506) 45.724 –0.012 (0.123) –1.227
Site (reference = Columbia)
Johns Hopkins –0.151 (0.137) –15.089 –0.604* (0.371) –60.363 –0.215** (0.103) –21.481
Massachusetts General –0.237 (0.123) –23.726 –0.354 (0.387) –35.448 –0.487*** (0.097) –48.732
DS score: range = 0–15; BDRS score: range = 0–17. Figures in parentheses indicate standard errors. * p < 0.10, ** p < 0.05, 
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 Adjusted Medical and Nonmedical Costs and Weekly 
Caregiving Hours 
 Table 4 presents our multivariate results on the effects 
of patient characteristics on medical cost, nonmedical 
cost, and informal caregiving time. Results showed that, 
after controlling for other covariates, both DS and BDRS 
scores were significantly associated with all three depen-
dent variables. Specifically, each additional point in DS 
score was associated with a 4.1% increase in informal 
caregivers’ time (p = 0.05), a 5.7% increase in medical cost 
(p = 0.031), and, although the effect was only marginally 
significant, a 10.5% increase in nonmedical cost (p = 
0.106). Each additional point in BDRS score was associ-
ated with an 8.7% increase in informal caregivers’ time 
(p = 0.032), a 7.6% increase in medical cost (p = 0.109), 
and a 3.9% increase in nonmedical cost (p = 0.019). The 
results also showed that one more comorbidity was asso-
ciated with a 19.2% increase in medical cost (p = 0.002).
 Secondary Analysis Estimating Informal Caregiving 
Costs 
 There is controversy in the approaches to value cost of 
caregivers’ time  [26] . The replacement wage approach is 
often used in the literature for its simplicity with the as-
sumption that wage rates used approximate prices paid 
for purchasing similar caregiving activities in the market. 
The alternative, opportunity cost approach, predicts the 
caregivers’ wage rate from individuals with similar char-
acteristics (e.g. age, gender, education, work experience). 
Although the opportunity cost approach is more consis-
tent with economic theory, lack of data on caregivers’ la-
bor force participation, as in this study, often precludes a 
detailed estimation of caregivers’ wage rates. To gauge the 
sensitivity of using different wage rates to value informal 
caregiving time, we used three replacement wage rates. 
The national average hourly earning for all private indus-
tries  [27] was used as a high estimate of caregivers’ time, 
the average wage rate for home health aides as a middle 
estimate, and the federal minimum wage as a low esti-
mate. In each valuation, informal caregiving cost was es-
timated by multiplying the hourly wage rate with the 
weekly hours of caregiving reported, and converting 
weekly cost to annual cost by multiplying by 52 (weeks 
per year). Using these wage rates, we estimated the low 
(high) cost of informal caregiving time at USD 2,391 
(USD 18,560) at baseline, increasing to USD 3,923 (USD 
32,862) in year 4. As the DS score increased, we estimated 
the cost of informal caregivers’ time to increase from 
USD 2,919 to USD 7,998 (low estimate) or from USD 
7,065 to USD 31,863 (high estimate).
 Discussion 
 AD has been characterized as impairments involving 
three main areas: cognition, function and behavior. Each 
of these characteristics has individually been analyzed 
with respect to their effect on patients’ health care cost. 
The DS was developed as a brief measure of AD patients’ 
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tients’ dependence on others and tracking changes in de-
pendence over time  [7] . It has been shown to change over 
time after accounting for changes in cognition or func-
tion, supporting its utility as a construct separate from 
functional disability  [8–10] . Until recently, however, there 
has been limited information on the ability of the DS to 
discern differences in cost of care  [4, 5, 11, 28] . The cur-
rent analysis builds on recent literature by establishing 
the relationship between DS and cost over time. This 
question was explored for medical cost, nonmedical cost, 
and informal caregiving time. Our results show after 
controlling for functional deficits, patients’ dependence 
was significantly associated with medical cost and infor-
mal caregiving time, and marginally significantly associ-
ated with nonmedical cost.
 This study has several limitations. First, patients in 
our sample, selected from academic AD centers and pre-
dominantly white and highly educated, may represent a 
nonrandom sample of AD patients in the community. 
Caution is needed in generalizing the results of this study. 
Second, data on patients’ health care costs were reported 
by informants, most of whom were patients’ primary 
caregivers. Although there is no reason to believe that 
caregivers’ reports of patients’ health care utilization are 
inaccurate  [29, 30] , it is possible that there are additional 
costs beyond those collected in the study. Third, it should 
be noted that we estimated costs associated with caring 
for patients with AD which are not incremental costs due 
to AD.
 The large variations in informal caregiving cost (and 
hence total cost) estimates using different wage rates 
should be noted. This wide variation in cost of care for 
AD patients is well known in the literature  [31] . Two of 
the main reasons for variation are types of resources (e.g. 
informal care, medical care services used) included in 
the studies and the methods of valuing these resources. 
Depending on the wage rates assigned to caregivers’ 
time, the magnitude of imputed informal cost and its 
proportion in total societal cost would vary. To address 
these issues and to increase transparency we have pro-
vided caregiving hours prior to applying any cost esti-
mates on caregiving time. However, valuation of infor-
mal caregiving time is important in order to obtain a 
sense of its magnitude as compared to direct cost of care. 
We estimated that total cost of caring for AD patients 
ranged from USD 13,178 at baseline to USD 22,385 at 
year 4 (low estimate using minimum wage) to USD 
30,544 at baseline to USD 50,174 at year 4 (high estimate 
using national average wage rate). These estimates are 
within the ranges reported in the literature and indicate 
the validity of the data collection process used in the Pre-
dictors Study.
 Confidence in our findings is strengthened by several 
factors. A major contribution of the present analysis lies 
in the careful diagnosis and clinical follow-up that pa-
tients received. Patients were followed prospectively, 
which eliminates the potential biases inherent in deriving 
information from retrospective chart reviews. Clinical 
signs of interest were ascertained and coded in a stan-
dardized fashion at each visit. Evaluations were per-
formed annually, which provides multiple assessments of 
cost and therefore permits more accurate coefficient es-
timates. Finally, patients were recruited at early disease 
stages and followed for long periods of time with high fol-
low-up rates. Analysis is not compressed in time and the 
cohort describes the full range of progression over time. 
At the time of these analyses, 5.5% of the cohort had miss-
ing follow-up information before the most updated data 
entry.
 The results of this analysis suggest that patients’ de-
pendence provides a significant contribution in explain-
ing variations in health care cost in AD and that small 
changes in dependence are associated with large changes 
in costs of care. Thus, interventions that enhance patient 
independence (or delay patients’ dependence) may be as-
sociated with cost savings. The traditional approach to 
managing AD focusing on identifying and handling pa-
tient symptoms may have been missing an important 
component in how we evaluate patients’ needs or depen-
dence on others. Focus on this area is of particular im-
portance for clinicians and policymakers in providing 
support to patients, planning patients’ future health care 
needs, and approaching management of AD patients.
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